Ironwood Pharmaceuticals (NASDAQ:IRWD) Price Target Lowered to $12.00 at Wells Fargo & Company
Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Free Report) had its price objective lowered by analysts at Wells Fargo & Company from $14.00 to $12.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has an “overweight” rating on the biotechnology company’s stock. Wells Fargo & Company‘s target price indicates […]
More Stories
TransMedics Group, Inc. (NASDAQ:TMDX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) have been given an average recommendation of “Moderate Buy” by...
Principal Financial Group, Inc. (NYSE:PFG) Receives Average Recommendation of “Hold” from Analysts
Shares of Principal Financial Group, Inc. (NYSE:PFG – Get Free Report) have received an average rating of “Hold” from the...
Insider Selling: Upwork Inc. (NASDAQ:UPWK) CEO Sells 20,000 Shares of Stock
Upwork Inc. (NASDAQ:UPWK – Get Free Report) CEO Hayden Brown sold 20,000 shares of the firm’s stock in a transaction...
SouthState Co. (NASDAQ:SSB) Insider Sells $250,000.00 in Stock
SouthState Co. (NASDAQ:SSB – Get Free Report) insider Daniel E. Bockhorst sold 2,500 shares of the business’s stock in a...
Citigroup Downgrades MKS Instruments (NASDAQ:MKSI) to Neutral
Citigroup cut shares of MKS Instruments (NASDAQ:MKSI – Free Report) from a buy rating to a neutral rating in a...
LKQ (NASDAQ:LKQ) Downgraded to Hold at StockNews.com
StockNews.com cut shares of LKQ (NASDAQ:LKQ – Free Report) from a buy rating to a hold rating in a research...